CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BiOptic Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BiOptic Inc
4F, No.108-3, Minquan
Road, Xindian Dist
Phone: +886 222188726p:+886 222188726 NEW TAIPEI, 231  Taiwan Ticker: 68506850
Business Summary
BiOptic Inc is a Taiwan-based company mainly engaged in research, development, production and sale of capillary electrophoresis apparatus and related consumables and nucleic acid detection reagents. The Company's main products include testing instruments, cassettes and reagents. The detection equipment includes Qsep100 series, Qsep1 series and Qsep400 series of capillary electrophoresis instruments for separation and detection of biomolecules. Cartridges include S1, S2, S3, F3 series for detecting different fragments of deoxyribonucleic acid (DNA), R1 and NR1 series for ribonucleic acid (RNA) detection, P2 series for protein detection and quantitative detection Q series. The reagents include polymerase chain reaction reagents, veterinary medicine-related reagents, human gene detection-related reagents and food-related reagents. The Company mainly provides its products in China, Hong Kong, Taiwan and other regions.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022Yes----

Industries
SIC Code Description
3826 Laboratory analytical instruments
3845 Electromedical and electrotherapeutic apparatus
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager ShouguanCai
Deputy General Manager-Research & Development, Director XianliangJi
Director XianqingLu 9/28/2021 9/28/2021
4 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 24,200,000 (As of 6/30/2023)
Stock Exchange: TPO
Fax Number: +886 222188727


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024